Assessment of bacteriological and immunological markers in urinary tract infection and the effect of antibiotics on the isolated bacteria
Abstract
Urinary tract infections (UTIs) are recognized as the second most common medical condition, following respiratory infections. Despite the availability of numerous efficacious antibiotics for the management of UTIs, the rising incidence of bacterial resistance presents significant challenges in the treatment of these infections. Bacteria are endowed with the ability to reproduce and develop resistance mechanisms against antibiotics. The current investigation aimed to evaluate the susceptibility of bacterial isolates from urinary tract infections (UTIs) to a variety of antibiotics, including ciprofloxacin, trimethoprim, amikacin, gentamicin, tetracycline, chloramphenicol, nalidixic acid, nitrofurantoin, meropenem, and novobiocin. Additionally, the study sought to quantify the levels of the inflammatory immune marker interleukin-6 (IL-6) in UTI patients. It also explored the correlation between IL-6 levels in UTI patients and healthy controls, as well as the relationship between IL-6 levels and blood parameters in both infected and healthy individuals. The present study involved the collection of 155 samples from patients diagnosed with urinary tract infections of both genders and varying age groups, ranging from 15 to 75 years, at Salah al-Din General Hospital. The findings revealed that 102 urine samples tested positive for bacterial growth, resulting in a prevalence rate of 68%. In contrast, 53 urine samples were negative for bacterial growth, reflecting a prevalence rate of…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 155 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.